Evaluation of Right Ventricular Function to Predict Weaning Success in the Intensive Care Unit
1 other identifier
observational
60
1 country
1
Brief Summary
The goal of this prospective observational study is to evaluate whether right ventricular (RV) function parameters assessed via transthoracic echocardiography (TTE) can predict weaning success in adult intensive care unit (ICU) patients who are mechanically ventilated. The main questions it aims to answer are: Can the TAPSE (Tricuspid Annular Plane Systolic Excursion) value predict successful extubation? Do other right heart parameters (tricuspid S', RV-FAC, right atrial area, pulmonary valve acceleration time) provide additional prognostic value for weaning outcomes? Participants will: Be adult ICU patients planned for weaning from mechanical ventilation. Undergo transthoracic echocardiography within 2 hours after meeting clinical weaning criteria. Have the following echocardiographic parameters measured: TAPSE, tricuspid S', RV-FAC, right atrial area, and pulmonary valve acceleration time. Be monitored for 24 hours after extubation to assess weaning success (defined as no need for reintubation, non-invasive ventilation, or high-flow oxygen support).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jul 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 10, 2025
CompletedFirst Posted
Study publicly available on registry
July 20, 2025
CompletedStudy Start
First participant enrolled
July 31, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 16, 2026
September 9, 2025
July 1, 2025
12 months
July 10, 2025
September 2, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Discriminative Ability of TAPSE for Predicting Weaning Success
Assessment of the predictive accuracy of TAPSE (Tricuspid Annular Plane Systolic Excursion) in identifying weaning success, defined as no requirement for reintubation, non-invasive ventilation, or high-flow oxygen within 24 hours post-extubation.
Within 24 hours after extubation
Secondary Outcomes (4)
Discriminative Ability of RV-FAC in Predicting Weaning Success
Within 24 hours after extubation
Discriminative Ability of Tricuspid S' Velocity in Predicting Weaning Success
Within 24 hours after extubation
Correlation of Right Atrial Area With Weaning Outcome
Within 24 hours after extubation
Correlation of Pulmonary Valve Acceleration Time with Predicting Weaning Success
Within 24 hours after extubation
Study Arms (1)
Mechanically Ventilated ICU Patients Undergoing Weaning
Adult patients receiving mechanical ventilation in the intensive care unit (ICU) who meet clinical criteria for planned weaning and extubation. All patients will undergo bedside transthoracic echocardiography (TTE) to assess right ventricular function prior to extubation.
Interventions
Non-invasive ultrasound imaging of the heart to evaluate right ventricular and right atrial function using parameters such as TAPSE, tricuspid S', RV-FAC, right atrial area, and pulmonary valve acceleration time. TTE will be performed once within 2 hours prior to extubation decision as part of routine care.
Eligibility Criteria
Adult patients who are receiving invasive mechanical ventilation in the intensive care unit (ICU) and are scheduled for planned extubation based on standard clinical weaning criteria. All participants must be hemodynamically stable and able to undergo transthoracic echocardiographic assessment prior to extubation.
You may qualify if:
- Receiving invasive mechanical ventilation in the ICU
- Planned extubation (weaning) according to standard clinical criteria
- Hemodynamically stable at the time of transthoracic echocardiography (TTE)
- Ability to undergo echocardiographic assessment within 2 hours prior to extubation
- Informed consent obtained from patient or legal representative
You may not qualify if:
- Known severe tricuspid valve disease or congenital heart disease
- Moderate to severe pericardial effusion or cardiac tamponade
- Inadequate acoustic window for transthoracic echocardiography
- Patients requiring urgent or unplanned extubation
- Use of extracorporeal life support (e.g., ECMO) at the time of assessment
- Known pulmonary embolism or acute cor pulmonale
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Health Science University İstanbul Kanuni Sultan Süleyman Education and Training Hospital
Istanbul, Istanbul, 34303, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Day
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- principal investigator
Study Record Dates
First Submitted
July 10, 2025
First Posted
July 20, 2025
Study Start
July 31, 2025
Primary Completion (Estimated)
July 15, 2026
Study Completion (Estimated)
July 16, 2026
Last Updated
September 9, 2025
Record last verified: 2025-07